Statements of Operations (USD $)	3 Months Ended		9 Months Ended		107 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
OPERATING EXPENSES
Research and development	$ 625,737	$ 1,359,205	$ 2,930,436	$ 3,279,220	$ 25,734,496
Refund credit research and development costs	0	0	0	0	(420,842)
General and administrative	607,628	831,353	1,943,123	1,748,582	14,957,971
Total operating expenses	1,233,365	2,190,558	4,873,559	5,027,802	40,271,625
LOSS FROM OPERATIONS	(1,233,365)	(2,190,558)	(4,873,559)	(5,027,802)	(40,271,625)
OTHER INCOME (EXPENSE):
Interest income	54,789	0	78,850		346,548
Interest expense	(2,725,716)	(822,278)	(2,972,216)	(770,825)	(3,149,254)
Amortization of discount on convertible debentures	(143,051)	0	(419,305)	0	(1,407,738)
Beneficial conversion feature of convertible debentures	0	0	0	0	(713,079)
Change in fair market value of derivatives	3,752,933	(669,753)	(73,342)	(896,302)	(1,364,208)
Other income (expense), net	938,955	(1,492,031)	(3,386,013)	(1,667,127)	(6,287,731)
LOSS BEFORE INCOME TAX PROVISION	(294,410)	(3,682,589)	(8,259,572)	(6,694,929)	(46,559,356)
INCOME TAX PROVISION	0	0	0	0	0
NET LOSS	$ (294,410)	$ (3,682,589)	$ (8,259,572)	$ (6,694,929)	$ (46,559,356)
NET LOSS PER COMMON SHARE - BASIC AND DILUTED: (in dollars per share)	$ (0.01)	$ (0.08)	$ (0.16)	$ (0.15)
Weighted average common shares outstanding - basic and diluted (in shares)	53,318,736	46,701,410	50,307,984	45,686,379